molecular physiology and biophysics

sad man
February 1, 2016

VUMC study may offer answers for treating depression in alcoholics

A study by researchers at Vanderbilt University Medical Center is offering a glimmer of hope to alcoholics who find it hard to remain sober because their abstinence is hounded by stubborn, difficult-to-treat depression.

By Bill Snyder
January 28, 2016

Award recognizes Niswender’s research achievements

Kevin Niswender, M.D., Ph.D., a physician-scientist at Vanderbilt University Medical Center whose work has helped advance understanding of diseases ranging from obesity to schizophrenia, is one of 10 recipients of the 2016 Harrington Scholar-Innovator Awards.

By Bill Snyder
brain
January 21, 2016

Study shows brain function differs in obese children

The brains of children who are obese function differently from those of children of healthy weight, and exhibit an “imbalance” between food-seeking and food-avoiding behaviors, researchers at Vanderbilt University Medical Center have found.

By Bill Snyder
microscope
December 28, 2015

The most popular research stories of 2015

With discoveries ranging from the origins of consciousness to the end of the universe, 2015 was a year of incredibly diverse research at Vanderbilt University.

By VUMC News and Communications
December 3, 2015

Kenworthy to chair NIH biochemistry study section

Anne Kenworthy, Ph.D., professor of Molecular Physiology and Biophysics, has been named to a two-year term as chair of the Biochemistry and Biophysics of Membranes Study Section in the Center for Scientific Review of the National Institutes of Health (NIH).

By Bill Snyder
November 24, 2015

Symposium highlights 90th anniversary of Molecular Physiology and Biophysics

The Department of Molecular Physiology and Biophysics (MPB) will celebrate its 90th anniversary on Dec. 3 with a day-long symposium entitled “Mus musculus (Latin for lab mouse): What does the future hold?”

By Bill Snyder
November 18, 2015

Fighting type 2 diabetes with FGF1

The growth factor FGF1 induces the growth of new insulin-producing beta cells and may help treat type 2 diabetes.
By VUMC News and Communications
September 8, 2015

Immune cells and obesity

Understanding how macrophage immune cells accumulate in fat tissue and contribute to the pathology of obesity could lead to the development of novel therapeutics for metabolic disorders.
By Leigh MacMillan
August 20, 2015

New therapeutic target for diabetes

The factor FoxM1 increases the proliferation and function of insulin-producing beta cells, making it an attractive therapeutic target for diabetes.
By Leigh MacMillan
July 29, 2015

In a zebrafish’s eye

Vanderbilt investigators demonstrate that a certain eye lens protein is evolutionarily conserved between zebrafish and rat, suggesting that zebrafish can be used as a model system to understand eye lens disorders such as cataracts.
By Sanjay Mishra
July 9, 2015

Signals of schizophrenia

Vanderbilt researchers have discovered a possible molecular mechanism of schizophrenia that could lead to new treatments for the disorder.
By VUMC News and Communications
June 11, 2015

A “CRISPR” way to study disease

Using revolutionary CRISPR technology, Vanderbilt investigators have developed a fast and simple method to simultaneously turn off multiple genes in order to study complex diseases.
By VUMC News and Communications
April 20, 2015

Boosting beta cells in diabetes

New findings suggest that it might be possible to treat diabetes by regenerating insulin-producing beta cells in the pancreas.
By Leigh MacMillan
1 … 4 5 6 7 8 … 11